Sunday, November 3, 2024
HomeTagsBid Price

Bid Price

Kintara Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement

Kintara Therapeutics, Inc.("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that the Company received...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics